DR. TERRY D WOOD MD
Prescription History 1609856426
Ophthalmology in Kahului, HI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. TERRY D WOOD MD, an active Ophthalmology specialist practicing in Kahului, HI. Our medical registry currently tracks 14 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,733 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 939 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other HI PrescribersVs. HI Avg |
|---|---|---|---|
| Latanoprost | 939 | $40.45 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 939 Medicare prescriptions for Latanoprost, about 6 times the volume of the typical Hawaii prescriber of this medication (157). Medicare paid an average of $40.45 per fill, versus $27.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 2,283.2 30-Day Fills standardized to 30-day supplies 67,670 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 276 | $23.07▼ below HI avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 276 Medicare prescriptions for Dorzolamide-Timolol, about 3 times the volume of the typical Hawaii prescriber of this medication (92). Medicare paid an average of $23.07 per fill, versus $27.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the HI average for this medication. 509.8 30-Day Fills standardized to 30-day supplies 15,287 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 110 | $43.75▼ below HI avg | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 110 Medicare prescriptions for Brimonidine Tartrate, about 1.8 times the volume of the typical Hawaii prescriber of this medication (62). Medicare paid an average of $43.75 per fill, versus $70.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the HI average for this medication. 209.5 30-Day Fills standardized to 30-day supplies 6,215 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 73 | $49.95 | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 73 Medicare prescriptions for Timolol Maleate, about the same volume as the typical Hawaii prescriber of this medication (77). Medicare paid an average of $49.95 per fill, versus $48.77 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 134.5 30-Day Fills standardized to 30-day supplies 3,879 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 65 | $585.32▼ below HI avg | ▲ More than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 65 Medicare prescriptions for Rocklatan, about 1.5 times the volume of the typical Hawaii prescriber of this medication (43). Medicare paid an average of $585.32 per fill, versus $654.17 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the HI average for this medication. 95.8 30-Day Fills standardized to 30-day supplies 2,514 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 52 | $25.04 | ≈ Typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 52 Medicare prescriptions for Ketorolac Tromethamine, about the same volume as the typical Hawaii prescriber of this medication (52). Medicare paid an average of $25.04 per fill, versus $24.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 56.6 30-Day Fills standardized to 30-day supplies 1,226 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 50 | $57.45 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 50 Medicare prescriptions for Prednisolone Acetate, about half the volume of the typical Hawaii prescriber of this medication (108). Medicare paid an average of $57.45 per fill, versus $55.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 64.9 30-Day Fills standardized to 30-day supplies 1,621 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 37 | $35.18 | ≈ Typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 37 Medicare prescriptions for Dorzolamide Hcl, about 84% of the volume of the typical Hawaii prescriber of this medication (44). Medicare paid an average of $35.18 per fill, versus $29.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 59 30-Day Fills standardized to 30-day supplies 1,755 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 36 | $15.29▼ below HI avg | ≈ Typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 36 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 78% of the volume of the typical Hawaii prescriber of this medication (46). Medicare paid an average of $15.29 per fill, versus $17.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the HI average for this medication. 36 30-Day Fills standardized to 30-day supplies 482 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 31 | $1,281.96 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 31 Medicare prescriptions for Restasis, about half the volume of the typical Hawaii prescriber of this medication (66). Medicare paid an average of $1,281.96 per fill, versus $1,172.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 58 30-Day Fills standardized to 30-day supplies 1,740 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 22 | $474.23▼ below HI avg | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 22 Medicare prescriptions for Lumigan, about half the volume of the typical Hawaii prescriber of this medication (42). Medicare paid an average of $474.23 per fill, versus $612.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the HI average for this medication. 38.4 30-Day Fills standardized to 30-day supplies 1,147 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 19 | $836.61 | ▼ Less than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 19 Medicare prescriptions for Rhopressa, about half the volume of the typical Hawaii prescriber of this medication (43). Medicare paid an average of $836.61 per fill, versus $608.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.2 30-Day Fills standardized to 30-day supplies 1,035 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 12 | $161.92▼ below HI avg | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 12 Medicare prescriptions for Brinzolamide, about a third of the volume of the typical Hawaii prescriber of this medication (32). Medicare paid an average of $161.92 per fill, versus $369.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the HI average for this medication. 28.8 30-Day Fills standardized to 30-day supplies 853 Days of Medication total across all patients in 2023 | |||
| Travoprost | 11 | $150.34▼ below HI avg | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 11 Medicare prescriptions for Travoprost, about half the volume of the typical Hawaii prescriber of this medication (21). Medicare paid an average of $150.34 per fill, versus $293.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average HI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the HI average for this medication. 14 30-Day Fills standardized to 30-day supplies 418 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. TERRY D WOOD MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Kahului, HI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among HI prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
